Neuralink has posted an update on the first human trial of its not-entirely-successful brain implant. The Neuralink blog post discusses the experiences of patient Noland Arbaugh, who has used the ...
Brain-computer interfaces have the potential to transform some people's lives, but they raise a host of ethical issues, too. Andriy Onufriyenko/Moment via Getty Images Neuralink’s coin-size device, ...
Neuralink’s disclosure last week that tiny wires inside the brain of its first patient had pulled out of position is an issue the Elon Musk company has known about for years, according to five people ...
You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Grace Kay Every time Grace publishes a story, you’ll get an alert straight to your inbox! Enter ...
Elon Musk announced Neuralink's breakthrough in restoring full body functionality for individuals with severed spinal cords.
The FDA asserted its commitment to conducting inspections post-approval, aiming to ensure the safety of human trials. Neuralink brain-chip technology seeks to allow paralyzed individuals to operate ...
The announcement follows two years of accelerated testing and regulatory navigation. Neuralink launched its first human trial in 2024, two years after the US Food and ...
NEW YORK -- Elon Musk's brain implant startup Neuralink is accepting applications for a second human trial participant to test its device, the billionaire said on X Friday. The request comes five ...
Elon Musk is going full throttle on plans to release brain-computer interface chips in the new year, announcing on Wednesday ...
Is the next great leap in human machine integration to come not from smartphones or AI chatbots, but from a coin-sized chip ...
Neuralink chief Elon Musk envisions a future in which it is common for robotic surgeons to install brain implants that upgrade people's vision or other abilities ...
Elon Musk, billionaire and founder of Neuralink, claims the company can restore full body functionality for individuals with ...